» Articles » PMID: 23259143

Therapeutic Potential of Autologous Stem Cell Transplantation for Cerebral Palsy

Overview
Publisher Wiley
Specialty General Surgery
Date 2012 Dec 22
PMID 23259143
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background. Cerebral palsy (CP) is a severe disabling disease with worldwide incidence being 2 to 3 per 1000 live births. CP was considered as a noncurable, nonreparative disorder, but stem cell therapy offers a potential treatment for CP. Objective. The present study evaluates the safety and efficacy of autologous bone-marrow-derived mononuclear cell (BMMNCs) transplantation in CP patient. Material and Methods. In the present study, five infusions of autologous stem cells were injected intrathecally. Changes in neurological deficits and improvements in function were assessed using Gross Motor Function Classification System (GMFCS-E&R) scale. Results. Significant motor, sensory, cognitive, and speech improvements were observed. Bowel and bladder control has been achieved. On the GMFCS-E&R level, the patient was promoted from grade III to I. Conclusion. In this study, we report that intrathecal infusion of autologous BMMNCs seems to be feasible, effective, and safe with encouraging functional outcome improvements in CP patient.

Citing Articles

A systematic review of cell therapy modalities and outcomes in cerebral palsy.

Akat A, Karaoz E Mol Cell Biochem. 2024; 480(2):891-922.

PMID: 39033213 DOI: 10.1007/s11010-024-05072-3.


The density of bone marrow mononuclear cells and CD34+ cells in patients with three neurologic conditions.

Nguyen K, Hoang N, Nguyen H, Thanh L BMC Neurol. 2023; 23(1):37.

PMID: 36690963 PMC: 9869514. DOI: 10.1186/s12883-023-03071-3.


Are We Getting It Right? A Scoping Review of Outcomes Reported in Cell Therapy Clinical Studies for Cerebral Palsy.

Finch-Edmondson M, Paton M, Honan I, Karlsson P, Stephenson C, Chiu D J Clin Med. 2022; 11(24).

PMID: 36555936 PMC: 9786692. DOI: 10.3390/jcm11247319.


The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

Zarrabi M, Ghahvechi Akbari M, Amanat M, Majmaa A, Moaiedi A, Montazerlotfelahi H BMC Neurol. 2022; 22(1):123.

PMID: 35351020 PMC: 8966246. DOI: 10.1186/s12883-022-02636-y.


Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review.

Ebrahimi A, Ahmadi H, Pourfraidon Ghasrodashti Z, Tanide N, Shahriarirad R, Erfani A Bosn J Basic Med Sci. 2021; 21(6):672-701.

PMID: 34255619 PMC: 8554700. DOI: 10.17305/bjbms.2021.5508.


References
1.
Li Y, Chopp M, Chen J, Wang L, Gautam S, Xu Y . Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab. 2000; 20(9):1311-9. DOI: 10.1097/00004647-200009000-00006. View

2.
Woodbury D, Schwarz E, Prockop D, Black I . Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000; 61(4):364-70. DOI: 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C. View

3.
Callera F, de Melo C . Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev. 2007; 16(3):461-6. DOI: 10.1089/scd.2007.0083. View

4.
Mezey E, Key S, Vogelsang G, Szalayova I, Lange G, Crain B . Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003; 100(3):1364-9. PMC: 298778. DOI: 10.1073/pnas.0336479100. View

5.
Park D, Borlongan C, Willing A, Eve D, Cruz L, Sanberg C . Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009; 18(9):985-98. DOI: 10.3727/096368909X471279. View